These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 239460)

  • 61. Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution.
    Suehiro K; Miyata T; Takeya H; Takamatsu J; Saito H; Murakawa M; Okamura T; Niho Y; Iwanaga S
    Thromb Res; 1990 Nov; 60(4):311-20. PubMed ID: 2087690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Origin of the high molecular weight activator of prekallikrein.
    Bagdasarian A; Lahiri B; Colman RW
    J Biol Chem; 1973 Nov; 248(22):7742-7. PubMed ID: 4127217
    [No Abstract]   [Full Text] [Related]  

  • 63. The action of factor Xa, thrombin and trypsin on human factor II.
    Kisiel W; Hanahan DJ
    Biochim Biophys Acta; 1973 Dec; 329(2):221-32. PubMed ID: 4797461
    [No Abstract]   [Full Text] [Related]  

  • 64. Coagulant protein of Russell's viper venom.
    Furie BC; Furie B
    Methods Enzymol; 1976; 45():191-205. PubMed ID: 1011991
    [No Abstract]   [Full Text] [Related]  

  • 65. Inhibition of human factor IXa by human antithrombin.
    Rosenberg JS; McKenna PW; Rosenberg RD
    J Biol Chem; 1975 Dec; 250(23):8883-8. PubMed ID: 1194266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor.
    Zur M; Nemerson Y
    J Biol Chem; 1980 Jun; 255(12):5703-7. PubMed ID: 7380833
    [No Abstract]   [Full Text] [Related]  

  • 67. [The effect of plasmin on kallikreinogen].
    Andreenko GV; Suvorov AV
    Biokhimiia; 1976 Mar; 41(3):557-61. PubMed ID: 132197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII.
    Seligsohn U; Osterud B; Griffin JH; Rapaport SI
    Thromb Res; 1978 Dec; 13(6):1049-56. PubMed ID: 749262
    [No Abstract]   [Full Text] [Related]  

  • 69. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.
    Osterud B; Bouma BN; Griffin JH
    J Biol Chem; 1978 Sep; 253(17):5946-51. PubMed ID: 681330
    [No Abstract]   [Full Text] [Related]  

  • 70. Application of factor VII-Sepharose affinity chromatography in the purification of human tissue factor apoprotein.
    Bom VJ; Ram IE; Alderkamp GH; Reinalda-Poot HH; Bertina RM
    Thromb Res; 1986 Jun; 42(5):635-43. PubMed ID: 3715822
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.
    Noyes CM; Griffith MJ; Roberts HR; Lundblad RL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4200-2. PubMed ID: 6603618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The interaction of Ca2+ with human Factor IX.
    Amphlett GW; Kisiel W; Castellino FJ
    Arch Biochem Biophys; 1981 May; 208(2):576-85. PubMed ID: 6973319
    [No Abstract]   [Full Text] [Related]  

  • 73. Functional characterization of single-chain factor X from rat liver.
    Willingham AK; Matschiner JT
    Arch Biochem Biophys; 1984 May; 230(2):543-52. PubMed ID: 6712251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.
    Berkner KL
    Methods Enzymol; 1993; 222():450-77. PubMed ID: 8412810
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies of human factor IX by a high-titred sheep antiserum against factor IX.
    Orstavik KH; Vennerod AM; Laake K
    Thromb Res; 1977 Nov; 11(5):653-62. PubMed ID: 412271
    [No Abstract]   [Full Text] [Related]  

  • 76. The binding of metal ions to bovine factor IX.
    Amphlett GW; Byrne R; Castellino FJ
    J Biol Chem; 1978 Oct; 253(19):6774-9. PubMed ID: 690125
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors affecting the evolution of factor XIa during blood coagulation.
    Kingdon HS; Lunblad RL; Dingman G
    J Lab Clin Med; 1975 May; 85(5):826-31. PubMed ID: 235595
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Properties of bovine factor IX (Christmas factor).
    Davie EW; Fujikawa K; Kato H; Legaz ME
    Ann N Y Acad Sci; 1975 Jan; 240():34-42. PubMed ID: 234217
    [No Abstract]   [Full Text] [Related]  

  • 79. Partial purification of factors XI and XIa: a comparison of their molecular size and structure.
    Connellan JM; Castaldi PA
    Thromb Res; 1975 Nov; 7(5):717-28. PubMed ID: 813327
    [No Abstract]   [Full Text] [Related]  

  • 80. THE REACTION BETWEEN ACTIVATED PLASMA THROMBOPLASTIN ANTECEDENT AND DIISOPROPYLPHOSPHOFLUORIDATE.
    KINGDON HS; DAVIE EW; RATNOFF OD
    Biochemistry; 1964 Feb; 3():166-73. PubMed ID: 14163936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.